Find an expert
Our panel of editors are available for interview
Dr James Mountford
Editor-in-Chief of BMJ Leader
Dr James Mountford is Director of Quality at Royal Free London NHS Foundation Trust. He worked initially as an NHS doctor, then in consulting. From 2005-2007, he was a Commonwealth Fund Health Foundation Harkness Fellow based in Massachusetts General Hospital, and at the Institute for Healthcare Improvement (IHI), both in Boston, USA. Before moving to the Royal Free, he was Director of Quality at UCL Partners, an academic health sciences partnership serving a population of 3 million in and around London. He sits on the board of AQuA, the improvement partnership based in north-west England. In March 2020 he was seconded to work as the Chief of Quality and Learning at the NHS Nightingale Hospital London, opened in response to the COVID-19 pandemic.
Professor Bryony Dean Franklin
Editor-in-Chief of BMJ Quality & Safety
Professor Bryony Dean Franklin is a hospital pharmacist by background, with 30 years’ experience of research into medication safety, medication use in practice and patient safety more generally. She is Co-Editor-in-Chief of BMJ Quality & Safety, Professor of Medication Safety at UCL School of Pharmacy, Executive Lead Pharmacist for Research at Imperial College Healthcare NHS Trust, Director of the NIHR North West London Patient Safety Research Collaboration and theme lead for the NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London. Professor Franklin has published widely on medication safety, the evaluation of various technologies designed to reduce errors, and the patient’s role in patient safety. Her current post combines research, quality improvement, education and training, medical publishing and hospital pharmacy practice.
Professor Gisli Jenkins
Chair of the Editorial Board for BMJ Open Respiratory Research
Professor Gisli Jenkins is an NIHR Research Professor and holds the Margaret Turner-Warwick Chair of Thoracic Medicine at Imperial College London, Head of the Margaret Turner-Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute. Prof Jenkins’ research focuses on Interstitial Lung Diseases, and Pulmonary Fibrosis in particular. He is the Principal Investigator of a number of longitudinal observational studies including the PROFILE study, the INJUSTIS Study, the UKILD Post COVID ILD study as well as the DEMISTIFI Multi-Morbidity consortium.
Dr Nick Brown
Editor-in-Chief of Archives of Disease in Childhood
Dr Nick Brown is a paediatrician and epidemiologist. His initial training was in the UK in general paediatrics, but for the last 25 years, he has had a parallel carer in academic international child health. Nick has lived and worked in Sudan, Afghanistan, Papua New Guinea, India and Pakistan, largely as an epidemiologist. He has a long affiliation with the Aga Khan University in Karachi where he teaches epidemiology, biostatistics and research methodology and is involved in studies in child pneumonia, rheumatic heart disease, thalassaemia and early child development. Nick is currently based in Sweden with a clinical position in Gavle and academic affiliation with the International Centre for Maternal and Child Health at Uppsala University.
Dr James Cave
Editor-in-Chief of the Drugs and Therapeutics Bulletin
Dr James Cave has been a GP for over 25 years. He currently works for Red Whale, providing courses for GP’s that take the latest research and demonstrate how it might be used in practice. James was awarded an OBE for services to medicine in 2009.
Professor Hans Kromhout
Editor-in-Chief of Occupational & Environmental Medicine
Professor Hans Kromhout is an occupational hygiene and epidemiology specialist, based at the Institute for Risk Assessment Sciences at Utrecht University in the Netherlands. Professor Kromhout’s work has covered the health effects of chemical and physical (EMF) agents in the workplace and general environment. He has been the (co-)PI of large international studies in among others the asphalt industry, rubber manufacturing industry, industrial minerals industry, health sector and agriculture and community based studies on cancer, respiratory diseases, neurodegenerative diseases and reproductive health effects.
